BRITTNY AHRENDES: Open Payments
NPI 1689846826 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,358 in 116 payments from 19 companies in 2025. Trend: 2023 $1,935 · 2024 $2,987 · 2025 $2,358
Food & beverage: $2,218Education: $140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $375 |
| Regeneron Healthcare Solutions, Inc. | 12 | $294 |
| PFIZER INC. | 15 | $242 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $215 |
| Galderma Laboratories, L.P. | 15 | $208 |
| UCB, Inc. | 10 | $170 |
| Janssen Biotech, Inc. | 6 | $164 |
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Organon LLC | 8 | $123 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
Products named: DUPIXENT, SKYRIZI, CIBINQO, NEMLUVIO, Bimzelx, TREMFYA, COSENTYX, RINVOQ.
Industry payments across NV — which companies pay providers there.
